ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,153.60
      1.03%
      Dow Jones
      38,085.80
      0.00%
      Brent Oil
      88.675
      0.60%
      Bitcoin
      64,215.98
      -0.42%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acadia Pharmaceuticals Inc (ACAD)

      7. Acadia Pharmaceuticals Inc (ACAD) News

      ACAD

      Acadia Pharmaceuticals (ACAD)

      Acadia Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACAD
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      04/24/20244:05PMBusiness WireAcadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
      04/22/20249:04AMBusiness WireAcadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health CanadaNASDAQ:ACADAcadia Pharmaceuticals Inc
      04/22/20249:04AMBusiness WireAcadia Pharmaceuticals annonce que la présentation de drogue nouvelle pour la trofinetide dans le traitement du syndrome de Rett a été acceptée pour dépôt et évaluation prioritaire par Santé CanadaNASDAQ:ACADAcadia Pharmaceuticals Inc
      04/19/20244:05PMBusiness WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
      04/17/20244:05PMBusiness WireAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:ACADAcadia Pharmaceuticals Inc
      04/02/20244:05PMBusiness WireAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and DevelopmentNASDAQ:ACADAcadia Pharmaceuticals Inc
      04/01/20244:05PMBusiness WireAcadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ACADAcadia Pharmaceuticals Inc
      03/15/20244:05PMBusiness WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
      03/13/20244:05PMBusiness WireAcadia Pharmaceuticals to Participate in the UBS Virtual CNS DayNASDAQ:ACADAcadia Pharmaceuticals Inc
      03/12/20247:21AMIH Market NewsOracle Soars 13% With Exceptional Growth and Boosts Nvidia Shares With Collaboration Announcement, and MoreNASDAQ:ACADAcadia Pharmaceuticals Inc
      03/11/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
      03/11/20244:05PMBusiness WireAcadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of SchizophreniaNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/29/20249:05AMBusiness WireAcadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
      02/27/20246:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/27/20246:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/27/20246:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/27/20246:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/27/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/27/20244:05PMBusiness WireAcadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating OverviewNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/21/20244:05PMBusiness WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
      02/14/20247:08AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/13/20244:05PMBusiness WireAcadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
      02/08/20245:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
      02/08/20245:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
      01/30/20249:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
      01/30/20248:48PMBusiness WireAcadia Announces Additions to Executive TeamNASDAQ:ACADAcadia Pharmaceuticals Inc
      01/26/20245:25PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACADAcadia Pharmaceuticals Inc
      01/19/20244:05PMBusiness WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
      01/18/20244:05PMBusiness WireAcadia Announces the Passing of Former President Srdjan (Serge) StankovicNASDAQ:ACADAcadia Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ACAD